JUL 13, 2016 8:33 AM PDT

Itaconate Metabolite Hijacks Macrophage Activation

WRITTEN BY: Kara Marker
Macrophages of the immune system are vital for mounting a quick and directed attack on invading pathogens especially along the inflammatory pathway, but often overzealous macrophages can go a bit too far and cause damage with excessive inflammation. Numerous immune suppression therapies exist on the market, but often they can render a person vulnerable to infection while trying to relieve an inflammatory disorder. A new option has surfaced in a new study: a natural metabolite that controls macrophage activity.
 Draw-bridge depicts Itaconate disrupting the TCA cycle flow - Credit: Aleksandra Ziminova
A collaboration of scientists from Washington University, ITMO University, McGill University, and the Max Planck Institute of Immunobiology and Epigenetics is behind the potential new option for suppressing inflammation: itaconate. Their findings were recently published in the journal Cell Metabolism.
 
Macrophages transition between three distinct stages during their lifetime: neutral (M0), pro-inflammatory (M1), and anti-inflammatory (M2). As expected, M1 macrophages are the type that arrives first at the scene of the crime, promoting inflammation to begin the immune attack on whatever pathogen has invaded the body. When a M1 macrophage becomes “overly diligent” though, numerous pathologies can result: cardiac ischemia, metabolic disorders, and even autoimmune diseases.
 
Too much inflammation is dangerous and leads to these diseases because of the absorption of energy resources required to keep the inflammatory pathway up and running. The new study looked at the transition process of macrophages between states, especially between their inactive and pro-inflammatory state. This is where itaconate comes into the picture, a natural metabolite released by macrophages whose role scientists have never quite understood – until now.
 
The researchers found that there seems to be a defined limit of the amount of itaconate that can be produced during the M0 – M1 transition, and as itaconate levels grow closer to the limit, macrophage activation to its pro-inflammatory state is designed to fail. “Itaconate sets the bar controlling M1 macrophage formation, said Alexey Sergushichev, one of the study’s authors.
 
Itaconate’s role within macrophage activation was finally realized when the researchers connected the metabolite to the bodily processes for producing energy from glucose oxidation: cellular respiration and the tricarboxylic acid cycle. An enzyme called succinate dehydrogenase (SDH) provides a component called fumarate to the tricarboxylic acid cycle. This is where the researchers saw itaconate interfering with energy production: itaconate blocks the enzyme entirely.
 
With the tricarboxylic acid cycle and cellular respiration halted without a necessary enzyme, macrophage activation to a pro-inflammatory state fails. In this way, itaconate acts as an anti-inflammatory agent, while it also acts as an antioxidant by blocking glucose oxidation.
 
The successful breakdown of itaconate and its role in macrophage activation is important for understanding how inflammatory diseases develop, as well as for how to treat them. Sergushichev believes that this new insight will lead to the ability of scientists to “artificially manipulate the transition of macrophages from M0 to M1, meaning the possibility of restraining inflammations.”
 


Sources: ITMO University, Current Opinion in Plant Biology
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 08, 2021
Health & Medicine
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
SEP 08, 2021
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
Researchers from the University of Oxford found an association between neuropeptide S receptor 1 (NPSR1) gene variants a ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
SEP 27, 2021
Cell & Molecular Biology
Newly Identified Cell Type is Linked to Chronic Skin Disorders
SEP 27, 2021
Newly Identified Cell Type is Linked to Chronic Skin Disorders
The chronic skin disease atopic dermatitis (AD) is estimated to affect about 15 percent of children worldwide, and for s ...
OCT 04, 2021
Health & Medicine
Guillain-Barre Syndrome After COVID-19 Infection
OCT 04, 2021
Guillain-Barre Syndrome After COVID-19 Infection
Researchers with the International GBS Outcome Study (IGOS) investigated newly-diagnosed GBS patients from the beginning ...
Loading Comments...